Delivery Order SPE2DB20D1051-SPE2DB24FD7PF
- Not listed
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML. The contract has a potential value of $12,697.79 and a completion date of January 31, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation for this award. The contract is part of a larger indefinite delivery...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML. The contract has a completion date of March 7, 2024 and a potential value of $7,079.93. This delivery order is issued under a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that runs through December 31, 2025, which...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,892,900 BOOSTRIX TDAP vaccine syringes (0.5 mL) with a completion date of March 8, 2024. The award, valued at $2,224.72, does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor and has previously received numerous federal contract awards from DLA for...
- The U.S. Defense Logistics Agency (DLA) awarded a $33,555.84 delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML. This order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order valued at $19,498.82 to Amerisourcebergen Drug Corp, a subsidiary of the for-profit organization Cencora, Inc. (also known as Amerisourcebergen). The delivery order is for the supply of 4,564,017,417 units of the BOOSTRIX TDAP VACCINE SYRINGE 0.5ML. This award does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor and is responsible for providing these pharmaceutical products to...
- This contract was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation. The $60,849.55 firm-fixed-price delivery order is for the provision of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML to the DLA. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. The IDC enables the DLA to...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order worth $1,265.40 to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distributor AmerisourceBergen Corporation. This order is for the BOOSTRIX TDAP VACCINE SYRINGE 0.5ML product and has an ultimate completion date of April 10, 2024. AmerisourceBergen Drug Corp holds a larger indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025. This IDC serves as...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 0.5 ml Boostrix TDAP vaccine syringes. The $1,466.17 award, which has no set-aside designation, is for delivery by December 22, 2023. Amerisourcebergen Drug Corp, as a prime contractor, has an extensive history of providing pharmaceuticals, medical supplies, and distribution services to support DLA programs....
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply BOOSTRIX TDAP VACCINE SYRINGE 0.5ML. The $100,028.32 contract has a completion date of September 8, 2021 and was awarded without any set-aside designation. Amerisourcebergen Drug Corp, through its Corporate Office division, has a history of providing pharmaceutical products and medical supplies to support DLA...
- This federal contract award is for the delivery of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML to the Defense Logistics Agency (DLA) Troop Support Medical. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is a firm fixed price delivery order with a potential value of $2,400.36 and a completion date of February 12, 2024. The contract does not have a set-aside...
- SPE2DB20D1051Indefinite Delivery Contract
- SPE2DB20D1051-SPE2DB24FD7PFDelivery Order
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML. The contract has a ceiling value of $2,723.48 and a period of performance through April 2, 2024. Amerisourcebergen Drug Corp is a prime contractor for DLA Troop Support Medical, providing a wide range of pharmaceutical products and medical supplies to support military treatment programs and facilities. This award is issued under an Indefinite Delivery Contract (IDC) with a potential value of $999,999,999.00 and a performance period through December 31, 2025, which serves as the primary contract vehicle for Amerisourcebergen to deliver medications and healthcare materials to DLA Troop Support Medical. The contract does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 4/1/24 |